Amir Shojaei

Amir Shojaei

Chief Tech/Sci/R&D Officer at HARROW, INC.

Net worth: - $ as of 2026-06-29

58 year
Health Technology
Consumer Services
Commercial Services

Profile

Amir H.
Shojaei
is Director at iVeena Delivery Systems, Inc. since 2020.
Dr. Shojaei is Executive Director at Forwardvue Pharma, Inc. since 2020.
Dr. Shojaei is Chief Scientific Officer at Harrow, Inc. starting 2025.
Former positions include Chief Executive Officer & Director at TherOptix, Inc., Vice President-Pharmaceutical Development at AGI Therapeutics Plc from 2007 to 2009, and Chief Scientific Officer & Executive VP at AsclepiX Therapeutics LLC.
Education includes a doctorate from the University of the Pacific.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-04-20 0 ( -.--% ) - $ 2026-06-29

Amir Shojaei active positions

CompaniesPositionStart
HARROW, INC. Chief Tech/Sci/R&D Officer 2025-01-06
Director/Board Member 2020-02-01
Director/Board Member 2020-08-25

Former positions of Amir Shojaei

CompaniesPositionEnd
Corporate Officer/Principal 2008-12-31
Chief Tech/Sci/R&D Officer -
Chief Executive Officer -
See the detail of Amir Shojaei's experience

Training of Amir Shojaei

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

26

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Consumer Services

Health Technology

Health Technology

Commercial Services

Electronic Technology

Health Services